Replies to post #171701 on Biotech Values

[biotech_researcher]

Ariad- $ARIA "cash at 9-30-13 sufficient fund operations mid-2015. ** Assumes [no] US revenue from Iclusig, partnering, or cap-raising activities.**" With Iclusig now back on the market, we should make it a little further.

[frontiers]

I agree the price is fair now and I sold all my ARIA today. The company is burning cash at a fast rate and with all these news trials that need to be started an offering or debt financing is likely.

Nice rational point of view. Well, the market's not rational. I shall be holding on to my shares and ride the coming tide of irrationality to carry the ARIA stock price much higher. I am holding on to every single share I have until I think the tide has crested.

I had a strong feeling that Iclusig would be back in the US when I bought a nice size block at $2.3 or so around Nov 16. I thought the FDA made a poor decision by withdrawing the drug in the first place and said so here, though many on this board were not convinced.

I intend to fully capitalize on my purchase.